Back to search

Article

Interleukin-36 promotes systemic Type-I IFN responses in severe psoriasis.

2018-12-14

Abstract excerpt

Psoriasis is an immune-mediated skin disorder associated with severe systemic co-morbidities. Both chronic and acute forms of the disease are characterised by abnormal interleukin (IL)-36 signalling. While the mechanisms whereby IL-36 promotes cutaneous inflammation are well established, its systemic effects have not been investigated. To address this issue, we initially measured leukocyte gene expression in gener...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0576f334-b380-56d2-b12c-9b3e54e5a726
DOI
10.1101/496851
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Interleukin-36 promotes systemic Type-I IFN responses in severe psoriasis.DOI 10.1101/496851
Select a neighboring publication to make it the new centre.